Elucidating the specific pharmacological system of motion (MOA) of naturally happening compounds is often challenging. While Tarselli et al. (sixty) created the initial de novo artificial pathway to conolidine and showcased that this By natural means developing compound efficiently suppresses responses to equally chemically induced and inflammation